Home
Conditions
Tetanus

Clinical trial condition

Tetanus

Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.

272 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Tetanus trial results

Completed

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

NCT00169442

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

GSK Investigational Site Pasay, Philippines

GSK Investigational Site Quezon City, Philippines

View Trial Details

Completed

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

NCT00627458

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Jarvenpaa, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

GSK Investigational Site Tampere, Finland

View Trial Details

Completed

Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants

NCT00158756

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Barnaul, Russia

GSK Investigational Site Ivanteevka Moscow Region, Russia

GSK Investigational Site Krasnoyarsk, Russia

GSK Investigational Site Moscow, Russia

View Trial Details

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

NCT00412854

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Mengshan, China

GSK Investigational Site Wuzhou, China

View Trial Details

Completed

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
Locations: GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany

GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany

View all 38 locations

View Trial Details

Completed

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

NCT01449812

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +11 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Derval, France

GSK Investigational Site La Chapelle-Basse-Mer, France

GSK Investigational Site La Riche, France

GSK Investigational Site Nantes, France

View all 15 locations

View Trial Details

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

NCT00610168

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations: GSK Investigational Site Turku, Finland

View Trial Details

Completed

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

NCT00317109

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: GSK Investigational Site Brits, South Africa

GSK Investigational Site Ga-Rankuwa, South Africa

GSK Investigational Site Rooihuiskraal, South Africa

View Trial Details

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site Genoa, Liguria, Italy

GSK Investigational Site Milan, Lombardy, Italy

GSK Investigational Site Novara, Piedmont, Italy

GSK Investigational Site Cagliari, Sardinia, Italy

View Trial Details

Tetanus

Tetanus trial results

Related conditions